Dongjian Pharma Limited
Summary
Dongjian Pharma Limited was set up on Wednesday the 25th of July 2018. Their current partial address is Dublin 2, and the company status is Normal. The company's current director has been the director of 0 other Irish companies. Dongjian Pharma Limited has 1 shareholder. This Irish company shares its Eircode with at least 266 other companies.
Credit Score
- Latest Credit Movement:
- Date of Last Movement:21/11/2024
- Latest Accounts Filed:24/10/2024
- Report Based On Accounts:31/12/2023
- Next Set of Accounts Due:30/09/2025
- Overdue:No
Credit Report
- Credit Report & Financials
- Company Printout Report
- Directors & Owners Report
- Bad Debt Judgments Report
- Mortgages Report
€9
Company Vitals
- Company Name:Dongjian Pharma Limited
- Time in Business:6 Years
- Company Number:630944
- Company Size:Medium Company
- Current Status:NORMAL
- Principal Activity:[4618] Agents Specialised in the Sale of Other Particular Products
- May Trade As:Dongjian Pharma Ltd
- Registered Address:49 Fitzwilliam Square,
Dublin 2
D02 N578
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Judgments
Discover poor payment histories of any company by searching our Judgment Database, for court actions brought against a company for non-payment of a debt. Plus get free Judgment monitoring alerts on this company for the next 12 months. Judgments are available as part of the Credit Report.
Judgment Report:
Search all Registered Bad Debt Judgments for Co. Name matches.
€5
Documents
| Document | Pages | Effective | Received | Buy |
|---|---|---|---|---|
| Form B1C - Annual Return General | 4 | 30/09/2024 | 24/10/2024 | |
| FINANCIAL STATEMENT | 20 | 30/09/2024 | 24/10/2024 | |
| B10 CHANGE IN DIRECTORS/SECRETARY | 4 | 02/09/2024 | 10/09/2024 | |
| FINANCIAL STATEMENT | 19 | 30/09/2023 | 17/10/2023 | |
| Form B1C - Annual Return General | 4 | 30/09/2023 | 17/10/2023 | |
| Constitution | 5 | 25/07/2018 | 18/07/2018 | |
| Certificate of Incorporation | 1 | 25/07/2018 | 18/07/2018 |